All News #Library
Biotech
NeuroBo Reports Positive Data From DA-1726 Trial For Obesity
30 Sep 2024 //
PR NEWSWIRE
NeuroBo Doses First Patient in Obesity Trial for DA-1726
17 Apr 2024 //
PR NEWSWIRE
NeuroBo Announces FDA Clearance of IND for a Phase 1 Clinical Trial of DA-1726
01 Feb 2024 //
PRESS RELEASE
NeuroBo Pharma` Novel GLP1R and GCGR Dual Agonist, DA-1726
27 Jun 2023 //
PR NEWSWIRE
NeuroBo Announces Acceptance of Theater Discussion of DA-1726
13 Jun 2023 //
PR NEWSWIRE

Market Place
Sourcing Support